Exyte
Corporate brand
UnclaimedExyte is a Germany-based engineering, procurement and construction company specializing in controlled and regulated production environments.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Exyte is an international engineering, design, procurement and construction group headquartered in Stuttgart, Germany. Its work is concentrated in technically demanding and highly regulated environments, particularly semiconductor manufacturing, life sciences, biopharmaceutical production, chemical facilities, battery plants and data centers. The company is especially associated with the planning and delivery of high-tech production facilities and cleanrooms, where temperature, humidity, air purity, pressure, contamination and process-flow requirements must be tightly controlled. The business traces its origins to 1912, when Karl Meissner and Paul Wurst founded Meissner + Wurst. During its first half-century, the company primarily manufactured extraction equipment, fans and ventilation technology. In the 1960s, it expanded into cleanroom technology and established an expertise that later became central to its identity. From the 1990s onward, the company broadened its geographic reach and technical scope through international offices, new business lines and acquisitions. The corporate structure changed repeatedly before the Exyte name emerged. Jenoptik acquired Meissner + Wurst in October 1994. In August 1998, it was combined with Zander Klimatechnik AG of Nuremberg to create M+W Zander. The building-services engineering business was separated in a management buyout in 2004 as M+W Zander Gebäudetechnik GmbH and was renamed Caverion Deutschland GmbH in February 2007. A Swiss investor, Springwater Capital, acquired M+W Zander in 2005. In 2008, the facility-management division was transferred to HSG, a company belonging to the Bilfinger Group. The remaining business subsequently operated as M+W Group, or M+W. Since 2009, M+W was wholly owned by the Austrian holding company Stumpf Group. In 2018, the group reorganized its activities and created the Exyte Group around its high-technology businesses. Semiconductor, battery, biopharmaceutical and life-sciences solutions, together with data-center services, were placed within Exyte. Other activities, particularly energy-related projects, continued under the M+W Group name. Exyte therefore represents the specialized high-tech portion of a broader corporate heritage rather than a completely new operating business. The company announced plans in 2018 for a public listing involving the sale of a larger minority stake, but the proposed initial public offering was postponed in October of that year because of unfavorable market conditions. In November 2022, BDT Capital Partners agreed to acquire a significant share of Exyte. The transaction changed the company's ownership structure while preserving its focus on high-growth infrastructure and manufacturing markets. Exyte has continued to expand through acquisitions. In March 2024, it announced the acquisition of CollabraTech Solutions, a Phoenix, Arizona-based provider of delivery systems and contract manufacturing services. Later in 2024, Exyte acquired TTP Group, a Europe-focused pharmaceutical and chemical consulting and engineering firm. These transactions broadened Exyte's capabilities in specialized production equipment, consulting and engineering for pharmaceutical and chemical customers. Exyte's business model combines consulting and conceptual design with detailed engineering, procurement, construction management, commissioning and related project services. Its customers operate facilities where production continuity, contamination control, regulatory compliance and rapid capacity expansion are commercially critical. The company is consequently positioned less as a consumer-facing brand than as a behind-the-scenes technology-infrastructure partner for advanced manufacturing and research industries.
History
Exyte developed from Meissner + Wurst, a German ventilation-technology business founded in 1912 by Karl Meissner and Paul Wurst. The original company manufactured extraction units, fans and other ventilation equipment. During the 1960s it moved into cleanroom technology, an area that became the foundation for its later work in semiconductor, pharmaceutical and other controlled-production facilities. The company entered a period of structural and ownership change from the 1990s onward. Jenoptik acquired Meissner + Wurst in October 1994. In August 1998, it merged the company with Zander Klimatechnik AG from Nuremberg, creating M+W Zander. The enlarged group expanded internationally, added new offices and broadened its activities through acquisitions and new technical disciplines. In 2004, the building-services engineering division was separated through a management buyout and operated as M+W Zander Gebäudetechnik GmbH. That business was renamed Caverion Deutschland GmbH in February 2007. In 2005, Swiss investor Springwater Capital acquired M+W Zander. The facility-management division was transferred in 2008 to HSG, which belonged to the Bilfinger Group. The remaining company then operated under the M+W Group or M+W name. Since 2009, the group was wholly owned by the Austrian holding company Stumpf Group. A major reorganization took place in 2018. The high-technology activities—including semiconductor, battery, biopharmaceutical and life-sciences solutions, as well as data-center services—were bundled into the Exyte Group. Other activities, especially energy-related projects, remained under the M+W Group brand. Exyte announced plans for a stock-market listing and a sale of a larger minority interest, but the planned IPO was postponed in October 2018 because of adverse market conditions. In November 2022, BDT Capital Partners agreed to acquire a significant share of Exyte. The company subsequently continued its growth through targeted acquisitions. In March 2024, it acquired CollabraTech Solutions of Phoenix, Arizona, a provider of delivery systems and contract manufacturing services. Later in 2024, it acquired TTP Group, a European-focused consulting and engineering company serving pharmaceutical and chemical customers. Today, Exyte operates as a specialist design, engineering, procurement and construction group. Its projects typically require integration of building systems, process utilities, cleanroom environments, production equipment, regulatory requirements and commissioning activities. Rather than selling standardized consumer products, it delivers complex facilities and technical services to industrial and scientific customers. Its historical continuity lies in ventilation and environmental control, while its modern identity is centered on advanced manufacturing infrastructure and controlled environments.
- 2024
CollabraTech Solutions acquired
[1]Exyte acquired CollabraTech Solutions, expanding its delivery-systems and contract-manufacturing capabilities.
- 2024
TTP Group acquired
[1]Exyte acquired TTP Group, adding European pharmaceutical and chemical consulting and engineering capabilities.
- 2022
BDT Capital Partners investment
[1]BDT Capital Partners agreed to acquire a significant share of Exyte.
- 2018
Exyte Group established
[1]The high-tech activities of M+W Group were reorganized under the Exyte Group name.
- 2009
Stumpf Group ownership
[1]The M+W Group became wholly owned by the Austrian holding company Stumpf Group.
- 2007
Caverion Deutschland name adopted
[1]M+W Zander Gebäudetechnik GmbH was renamed Caverion Deutschland GmbH in February 2007.
- 2004
Building-services division spun off
[1]The building-services engineering division left the group through a management buyout and became M+W Zander Gebäudetechnik GmbH.
- 1998
Creation of M+W Zander
[1]Meissner + Wurst was merged with Zander Klimatechnik AG in August 1998 to form M+W Zander.
- 1994
Acquisition by Jenoptik
[1]Jenoptik acquired Meissner + Wurst in October 1994.
- 1960
Expansion into cleanroom technology
[1]During the 1960s, Meissner + Wurst established itself in cleanroom technology, creating the technical base for later high-tech facility work.
Products and positioning
A specialist engineering and construction partner for high-technology, cleanroom-dependent and regulated production environments.
Controlled environments
Cleanroom and contamination-control facilities
Exyte designs and delivers cleanrooms and associated environmental-control systems for industries in which airborne particles, temperature, humidity, pressure and contamination must be managed closely. These facilities support semiconductor fabrication, pharmaceutical production, biotechnology and other sensitive manufacturing processes.
Advanced manufacturing infrastructure
Semiconductor facilities
The semiconductor business covers planning, engineering and construction services for high-tech production plants. Projects may integrate cleanrooms, process utilities, building systems and commissioning requirements needed for complex semiconductor manufacturing environments.
Pharmaceutical and biotechnology infrastructure
Life-sciences and biopharmaceutical facilities
Exyte provides facility engineering and project-delivery services for pharmaceutical, biopharmaceutical and life-sciences customers. Its work addresses controlled environments, process integration and the regulatory and qualification demands associated with production and research facilities.
Energy and advanced manufacturing infrastructure · 2018
Battery manufacturing facilities
Battery-related services form part of the high-technology activities grouped under Exyte in 2018. The offering involves engineering and delivery of specialized production environments and supporting infrastructure for battery manufacturing projects.
Chemical industry engineering
Chemical facilities
Exyte serves chemical-industry customers through consulting, engineering and project-delivery capabilities. The acquisition of TTP Group further strengthened the company's European pharmaceutical and chemical consulting and engineering activities.
Digital infrastructure · 2018
Data-center infrastructure
Data-center services are among the activities assigned to Exyte during the 2018 reorganization. The business supports the planning and delivery of infrastructure for facilities requiring dependable power, cooling, environmental control and highly coordinated construction.
Specialized manufacturing services · 2024
Delivery systems and contract manufacturing services
Through the 2024 acquisition of CollabraTech Solutions, Exyte added delivery-systems and contract-manufacturing capabilities serving specialized industrial and high-technology applications.
Brand decisions
2024
Acquisition of CollabraTech SolutionsM&ABackground
Exyte sought to broaden its capabilities in specialized high-technology equipment and manufacturing services.
Action taken
Exyte acquired Phoenix-based CollabraTech Solutions, a delivery-systems and contract-manufacturing services company.
Aftermath
The acquisition expanded Exyte's service capabilities in specialized industrial applications. The purchase price was not disclosed.
2024
Acquisition of TTP GroupM&ABackground
Exyte's life-sciences and chemical-industry activities required additional consulting and engineering depth.
Action taken
Exyte acquired TTP Group, a European pharmaceutical and chemical consulting and engineering firm.
Aftermath
The transaction strengthened Exyte's capabilities for pharmaceutical and chemical customers in Europe.
2022
BDT Capital Partners investmentM&ABackground
Exyte pursued continued development of its high-technology engineering and construction activities.
Action taken
BDT Capital Partners agreed to acquire a significant share of Exyte.
Aftermath
The transaction introduced a new significant financial investor; the supplied material does not specify the exact ownership percentage or consideration.
2018
Reorganization into Exyte GroupStrategyBackground
M+W Group contained a range of businesses, while its high-technology activities were increasingly focused on advanced manufacturing and controlled environments.
Action taken
The semiconductor, battery, biopharmaceutical, life-sciences and data-center businesses were grouped under the Exyte Group name, while other mainly energy-related activities continued under M+W Group.
Aftermath
Exyte became the identifiable high-tech engineering and construction brand within the reorganized group.
2018
Planned IPO postponedOtherBackground
Exyte announced plans to sell a larger minority stake through a public listing, but market conditions became unfavorable.
Action taken
The proposed initial public offering was postponed in October 2018.
Aftermath
No subsequent listing is identified in the supplied reference material.
Recent events
Reported
Exyte completes acquisition of CPS Group[2]
Exyte completed its all-share acquisition of US-based Critical Process Systems Group from Wynnchurch Capital.
Reported
Exyte agrees to acquire CPS Group[3]
Exyte and Wynnchurch Capital announced an agreement for Exyte to acquire all of Critical Process Systems (CPS) Group. The transaction required regulatory approval and was expected to close in the fourth quarter of 2021.
Reported
Siemens and Exyte announce biopharmaceutical facility solution partnership[4]
Siemens and Exyte announced a collaboration to combine their digital and facility technologies to provide end-to-end solutions for the biopharmaceutical industry. The solution combines Siemens process automation and digitalization with Exyte’s rapid-build ExyCell modular technology.
Reported
Exyte and Univercells Technologies announce global partnership[5]
Exyte and Univercells Technologies announced a global partnership to jointly optimize the modular, standardized and flexible construction of GMP-standard vaccine production facilities.
Sources7 sources
Cite this profile: Cite the canonical profile. /brand-wiki/exyte · Editorial policy · How profiles are compiled